Endothelial progenitor cells in regenerative medicine and cancer: a decade of research

Trends in Biotechnology

Volumn 26, Issue 5, 2008, Pages 276-283

  Roncalli, Jerome G ^a   Tongers, Jörn ^a   Renault, Marie Ange ^a   Losordo, Douglas W ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; DRUG THERAPY; MEDICINE;

BONE MARROW; ENDOTHELIAL PROGENITOR CELLS (EPCS);

ENDOTHELIAL CELLS;

BASIC FIBROBLAST GROWTH FACTOR; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; ERYTHROPOIETIN; ESTROGEN; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINE; PLACENTAL GROWTH FACTOR; PLERIXAFOR; VASCULOTROPIN;

ANGIOGENESIS; BONE DEVELOPMENT; BONE INJURY; BONE MARROW; CANCER RESEARCH; CANCER THERAPY; CARCINOGENESIS; CD34 SELECTION; CELL DIFFERENTIATION; CELL LINEAGE; CELL SUBPOPULATION; CELL SURVIVAL; ENDOTHELIUM CELL; HEART MUSCLE ISCHEMIA; HUMAN; IONIZING RADIATION; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; RHEUMATOID ARTHRITIS; STEM CELL; STEM CELL MOBILIZATION; WOUND HEALING;

ANIMALS; BIOMEDICAL RESEARCH; CARDIOVASCULAR DISEASES; ENDOTHELIAL CELLS; GENETIC ENGINEERING; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; REGENERATIVE MEDICINE; STEM CELLS;

EID: 42149158211     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibtech.2008.01.005     Document Type: Review

References (89)

1. Asahara T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
2. Kalka C., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 3422-3427
3. Aoki M., et al. Derivation of functional endothelial progenitor cells from human umbilical cord blood mononuclear cells isolated by a novel cell filtration device. Stem Cells 22 (2004) 994-1002
4. Urbich C., and Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 95 (2004) 343-353
5. Rohde E., et al. Blood monocytes mimic endothelial progenitor cells. Stem Cells 24 (2006) 357-367
6. Yoder M.C., et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109 (2007) 1801-1809
7. Peichev M., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958
8. Reyes M., et al. Origin of endothelial progenitors in human postnatal bone marrow. J. Clin. Invest. 109 (2002) 337-346
9. Asai J., et al. Topical sonic hedgehog gene therapy accelerates wound healing in diabetes by enhancing endothelial progenitor cell-mediated microvascular remodeling. Circulation 113 (2006) 2413-2424
10. Losordo D.W., et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98 (1998) 2800-2804
11. Folkman J., et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339 (1989) 58-61
12. Risau W., and Flamme I. Vasculogenesis. Annu. Rev. Cell Dev. Biol. 11 (1995) 73-91
13. Lyden D., et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7 (2001) 1194-1201
14. Gunsilius E., et al. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet 355 (2000) 1688-1691
15. Hill J.M., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348 (2003) 593-600
16. Asahara T., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85 (1999) 221-228
17. Asahara T., et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 18 (1999) 3964-3972
18. Takahashi T., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5 (1999) 434-438
19. Gill M., et al. Vascular trauma induces rapid but transient mobilization of VEGFR(+)AC133(+) endothelial precursor cells. Circ. Res. 88 (2001) 167-174
20. Shintani S., et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103 (2001) 2776-2779
21. Rafii S., and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 9 (2003) 702-712
22. Werner N., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 353 (2005) 999-1007
23. Fujii H., et al. C-reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2476-2482
24. Sandri M., et al. Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. Circulation 111 (2005) 3391-3399
25. Kalka C., et al. Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ. Res. 86 (2000) 1198-1202
26. Dimmeler S., et al. HMG-CoA-reductase inhibitors (statins) increase endothelial progenitor cells via the P13 kinase/Akt pathway. J. Clin. Invest. 108 (2001) 391-397
27. Rupp S., et al. Statin therapy in patients with coronary artery disease improves the impaired endothelial progenitor cell differentiation into cardiomyogenic cells. Basic Res. Cardiol. 99 (2004) 61-68
28. Leyland-Jones B. Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol. 4 (2003) 459-460
29. Aicher A., et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 107 (2003) 2134-2139
30. Minatoguchi S., et al. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 109 (2004) 2572-2580
31. Orlic D., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 10344-10349
32. Ripa R.S., et al. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 113 (2006) 1983-1992
33. Crawford J., et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N. Engl. J. Med. 325 (1991) 164-170
34. Natori T., et al. G-CSF stimulates angiogenesis and promotes tumor growth: potential contribution of bone marrow-derived endothelial progenitor cells. Biochem. Biophys. Res. Commun. 297 (2002) 1058-1061
35. Hershman D., et al. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J. Natl. Cancer Inst. 99 (2007) 196-205
36. Liles W.C., et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 102 (2003) 2728-2730
37. Aiuti A., et al. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J. Exp. Med. 185 (1997) 111-120
38. Heeschen C., et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102 (2003) 1340-1346
39. Prunier F., et al. Delayed erythropoietin therapy reduces post-MI cardiac remodeling only at a dose that mobilizes endothelial progenitor cells. Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H522-H529
40. Littlewood T.J., et al. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J. Clin. Oncol. 19 (2001) 2865-2874
41. Yasuda Y., et al. Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis 24 (2003) 1021-1029
42. Kawamoto A., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103 (2001) 634-637
43. Tateishi-Yuyama E., et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360 (2002) 427-435
44. Inaba S., et al. Peripheral-blood or bone-marrow mononuclear cells for therapeutic angiogenesis?. Lancet 360 (2002) 2083
45. Schachinger V., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J. Am. Coll. Cardiol. 44 (2004) 1690-1699
46. Losordo D.W., et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation 115 (2007) 3165-3172
47. Badorff C., et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 107 (2003) 1024-1032
48. Schachinger V., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 355 (2006) 1210-1221
49. Assmus B., et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med. 355 (2006) 1222-1232
50. Koyanagi M., et al. Differentiation of circulating endothelial progenitor cells to a cardiomyogenic phenotype depends on E-cadherin. FEBS Lett. 579 (2005) 6060-6066
51. Numaguchi Y., et al. The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction. Circulation 114 (2006) I114-I119
52. Murasawa S., et al. Niche-dependent translineage commitment of endothelial progenitor cells, not cell fusion in general, into myocardial lineage cells. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1388-1394
53. Murry C.E., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664-668
54. Rodriguez-Merchan E.C., and Forriol F. Nonunion: general principles and experimental data. Clin. Orthop. Relat. Res. 419 (2004) 4-12
55. Colnot C.I., and Helms J.A. A molecular analysis of matrix remodeling and angiogenesis during long bone development. Mech. Dev. 100 (2001) 245-250
56. Gerstenfeld L.C., et al. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J. Cell. Biochem. 88 (2003) 873-884
57. Karsenty G., and Wagner E.F. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2 (2002) 389-406
58. Long M.W., et al. Expression of human bone-related proteins in the hematopoietic microenvironment. J. Clin. Invest. 86 (1990) 1387-1395
59. Chen J.L., et al. Osteoblast precursor cells are found in CD34+ cells from human bone marrow. Stem Cells 15 (1997) 368-377
60. Ford J.L., et al. Endochondral ossification in fracture callus during long bone repair: the localisation of 'cavity-lining cells' within the cartilage. J. Orthop. Res. 22 (2004) 368-375
61. Matsumoto T., et al. Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing. Am. J. Pathol. 169 (2006) 1440-1457
62. Snowden J.A., et al. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR. J. Rheumatol. 31 (2004) 482-488
63. Li J., et al. Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microsc. Res. Tech. 60 (2003) 107-114
64. Martin P. Wound healing-aiming for perfect skin regeneration. Science 276 (1997) 75-81
65. Galiano R.D., et al. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am. J. Pathol. 164 (2004) 1935-1947
66. Montesinos M.C., et al. Adenosine A(2A) receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis. Am. J. Pathol. 164 (2004) 1887-1892
67. Fontanini G., et al. Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study. J. Natl. Cancer Inst. 89 (1997) 881-886
68. Pastorino U., et al. Immunocytochemical markers in stage I lung cancer: relevance to prognosis. J. Clin. Oncol. 15 (1997) 2858-2865
69. Ohta Y., et al. Tumor angiogenesis and recurrence in stage I non-small cell lung cancer. Ann. Thorac. Surg. 68 (1999) 1034-1038
70. Macchiarini P., et al. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 340 (1992) 145-146
71. De Palma M., et al. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat. Med. 9 (2003) 789-795
72. Hilbe W., et al. CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J. Clin. Pathol. 57 (2004) 965-969
73. Ruzinova M.B., et al. Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell 4 (2003) 277-289
74. Peters B.A., et al. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat. Med. 11 (2005) 261-262
75. Hendry J.H., et al. Tumour stem cells: the relevance of predictive assays for tumour control after radiotherapy. Radiother. Oncol. 30 (1994) 11-16
76. Trott K.R. Tumour stem cells: the biological concept and its application in cancer treatment. Radiother. Oncol. 30 (1994) 1-5
77. Garcia-Barros M., et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300 (2003) 1155-1159
78. Paris F., et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293 (2001) 293-297
79. Fuks Z., et al. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res. 54 (1994) 2582-2590
80. Heissig B., et al. Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization. J. Exp. Med. 202 (2005) 739-750
81. Urbich C., et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J. Mol. Cell. Cardiol. 39 (2005) 733-742
82. Kawamoto A., et al. Synergistic effect of bone marrow mobilization and vascular endothelial growth factor-2 gene therapy in myocardial ischemia. Circulation 110 (2004) 1398-1405
83. Abbott J.D., et al. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110 (2004) 3300-3305
84. Kastrup J., et al. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial. J. Am. Coll. Cardiol. 45 (2005) 982-988
85. Ripa R.S., et al. Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease. Eur. Heart J. 27 (2006) 1785-1792
86. Kusano K.F., et al. Sonic hedgehog myocardial gene therapy: tissue repair through transient reconstitution of embryonic signaling. Nat. Med. 11 (2005) 1197-1204
87. Shea L.D., et al. DNA delivery from polymer matrices for tissue engineering. Nat. Biotechnol. 17 (1999) 551-554
88. Murohara T., et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 105 (2000) 1527-1536
89. Murasawa S., and Asahara T. Gene modified cell transplantation for vascular regeneration. Curr. Gene Ther. 7 (2007) 1-6